FDA Inspection 1302674 — Uproar Wellness, LLC
The FDA completed an inspection of Uproar Wellness, LLC on Feb 5, 2026 in Houston, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Tobacco.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- Feb 5, 2026
- Fiscal Year
- 2026
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Houston, TX (United States)